Screener

Eligibility screening

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Sponsored by Eli Lilly and CompanyStudy detailsClinicalTrials.gov

41 US sites in AR, AZ, CA, CO +22

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.